Literature DB >> 26944284

A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5.

Kavita Shah1, Debomoy K Lahiri2.   

Abstract

Cdk5, a cyclin-dependent kinase family member, is a global orchestrator of neuronal cytoskeletal dynamics. During embryogenesis, Cdk5 is indispensable for brain development. In adults, it is essential for numerous neuronal processes, including higher cognitive functions such as learning and memory formation, drug addiction, pain signaling, and long-term behavior changes through long-term potentiation and long-term depression, all of which rely on rapid alterations in the cytoskeleton. Cdk5 activity becomes deregulated in various brain disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, attention-deficit hyperactivity disorder, epilepsy, schizophrenia, and ischemic stroke; these all result in profound remodeling of the neuronal cytoskeleton. This Commentary specifically focuses on the pleiotropic contribution of Cdk5 in regulating neuronal microtubule remodeling. Because the vast majority of the physiological substrates of Cdk5 are associated with the neuronal cytoskeleton, our emphasis is on the Cdk5 substrates, such as CRMP2, stathmin, drebrin, dixdc1, axinMAP2, MAP1B, doublecortin, kinesin-5, and tau, that have allowed to unravel the molecular mechanisms through which Cdk5 exerts its divergent roles in regulating neuronal microtubule dynamics, both in healthy and disease states.

Entities:  

Keywords:  Alzheimer disease; Cdk5; Cytoskeleton; Microtubules; Neurodegeneration; p25; p35

Mesh:

Substances:

Year:  2016        PMID: 26944284      PMCID: PMC5011452          DOI: 10.1007/s12035-016-9792-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  112 in total

1.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2.

Authors:  M Venturin; P Guarnieri; F Natacci; M Stabile; R Tenconi; M Clementi; C Hernandez; P Thompson; M Upadhyaya; L Larizza; P Riva
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

2.  An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator.

Authors:  D Tang; J Yeung; K Y Lee; M Matsushita; H Matsui; K Tomizawa; O Hatase; J H Wang
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

3.  Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism.

Authors:  Wing-Yu Fu; Yu Chen; Mustafa Sahin; Xiao-Su Zhao; Lei Shi; Jay B Bikoff; Kwok-On Lai; Wing-Ho Yung; Amy K Y Fu; Michael E Greenberg; Nancy Y Ip
Journal:  Nat Neurosci       Date:  2006-12-03       Impact factor: 24.884

4.  Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.

Authors:  Paul J Muchowski; Ke Ning; Crislyn D'Souza-Schorey; Stanley Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.

Authors:  J A Bibb; J Chen; J R Taylor; P Svenningsson; A Nishi; G L Snyder; Z Yan; Z K Sagawa; C C Ouimet; A C Nairn; E J Nestler; P Greengard
Journal:  Nature       Date:  2001-03-15       Impact factor: 49.962

6.  Cyclin-dependent kinase 5 controls TRPV1 membrane trafficking and the heat sensitivity of nociceptors through KIF13B.

Authors:  Bao-Ming Xing; Yan-Rui Yang; Jun-Xia Du; Hai-Jing Chen; Cai Qi; Zhi-Hua Huang; Ying Zhang; Yun Wang
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

7.  Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease.

Authors:  Kai-Hui Sun; Yolanda de Pablo; Fabien Vincent; Emmanuel O Johnson; Angela K Chavers; Kavita Shah
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

8.  Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Authors:  Hiroyuki Kobayashi; Taro Saito; Ko Sato; Kotaro Furusawa; Tomohisa Hosokawa; Koji Tsutsumi; Akiko Asada; Shinji Kamada; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

9.  Drebrin controls neuronal migration through the formation and alignment of the leading process.

Authors:  Xin-peng Dun; Tiago Bandeira de Lima; James Allen; Sara Geraldo; Phillip Gordon-Weeks; John K Chilton
Journal:  Mol Cell Neurosci       Date:  2012-01-26       Impact factor: 4.314

10.  Kinesin-5 regulates the growth of the axon by acting as a brake on its microtubule array.

Authors:  Kenneth A Myers; Peter W Baas
Journal:  J Cell Biol       Date:  2007-09-10       Impact factor: 10.539

View more
  18 in total

Review 1.  Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.

Authors:  Kavita Shah; Sandra Rossie
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

2.  The transcription factor XBP1 in memory and cognition: Implications in Alzheimer disease.

Authors:  Moustapha Cissé; Eric Duplan; Frédéric Checler
Journal:  Mol Med       Date:  2017-01-04       Impact factor: 6.354

3.  The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.

Authors:  Kumar Nikhil; Kavita Shah
Journal:  J Cell Sci       Date:  2017-07-27       Impact factor: 5.285

4.  Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.

Authors:  Kumar Nikhil; Keith Viccaro; Kavita Shah
Journal:  Mol Neurobiol       Date:  2018-06-08       Impact factor: 5.590

5.  Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.

Authors:  Binukumar Bk; Susan Skuntz; Michaela Prochazkova; Sashi Kesavapany; Niranjana D Amin; Varsha Shukla; Philip Grant; Ashok B Kulkarni; Harish C Pant
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 6.  ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.

Authors:  Amrita Ramkumar; Brigette Y Jong; Kassandra M Ori-McKenney
Journal:  Dev Dyn       Date:  2017-10-27       Impact factor: 3.780

Review 7.  Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.

Authors:  Pradeepkiran Jangampalli Adi; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-04-30       Impact factor: 6.633

8.  Stress-induced Cdk5 activity enhances cytoprotective basal autophagy in Drosophila melanogaster by phosphorylating acinus at serine437.

Authors:  Nilay Nandi; Lauren K Tyra; Drew Stenesen; Helmut Krämer
Journal:  Elife       Date:  2017-12-11       Impact factor: 8.140

Review 9.  Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.

Authors:  Jaume Folch; Oriol Busquets; Miren Ettcheto; Elena Sánchez-López; Ruben Dario Castro-Torres; Ester Verdaguer; Maria Luisa Garcia; Jordi Olloquequi; Gemma Casadesús; Carlos Beas-Zarate; Carme Pelegri; Jordi Vilaplana; Carme Auladell; Antoni Camins
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Cyclin-dependent kinases and rare developmental disorders.

Authors:  Pierre Colas
Journal:  Orphanet J Rare Dis       Date:  2020-08-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.